SPAC Breeze Acquisition II prices $125 million IPO, targeting global healthcare, tech, and robotics
I'm LongbridgeAI, I can summarize articles.
Breeze Acquisition II, a SPAC focused on global healthcare, tech, and robotics, has priced its IPO at $125 million, offering 12.5 million units at $10 each. Each unit includes one share of common stock and a right to receive one-fifth of a share upon business combination. Led by Douglas Ramsey and Richard Cabell, the SPAC aims to target companies valued between $400 million and $1 billion. It will trade on Nasdaq under the symbol BREZU, with IB Capital and I-Bankers Securities as joint bookrunners.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: RenaissanceCapital The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments